GB0125492D0 - Formulation - Google Patents

Formulation

Info

Publication number
GB0125492D0
GB0125492D0 GBGB0125492.9A GB0125492A GB0125492D0 GB 0125492 D0 GB0125492 D0 GB 0125492D0 GB 0125492 A GB0125492 A GB 0125492A GB 0125492 D0 GB0125492 D0 GB 0125492D0
Authority
GB
United Kingdom
Prior art keywords
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0125492.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GBGB0125492.9A priority Critical patent/GB0125492D0/en
Publication of GB0125492D0 publication Critical patent/GB0125492D0/en
Priority to PCT/GB2002/004835 priority patent/WO2003035043A2/en
Priority to EP02774953A priority patent/EP1448171A2/en
Priority to AU2002341145A priority patent/AU2002341145A1/en
Priority to US10/493,166 priority patent/US20050042279A1/en
Priority to JP2003537610A priority patent/JP2005508971A/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0125492.9A 2001-10-24 2001-10-24 Formulation Ceased GB0125492D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB0125492.9A GB0125492D0 (en) 2001-10-24 2001-10-24 Formulation
PCT/GB2002/004835 WO2003035043A2 (en) 2001-10-24 2002-10-23 Pharmaceutical formulation comprising more than 15% tamoxifen
EP02774953A EP1448171A2 (en) 2001-10-24 2002-10-23 Pharmaceutical formulation comprising more than 15% tamoxifen
AU2002341145A AU2002341145A1 (en) 2001-10-24 2002-10-23 Pharmaceutical formulation comprising more than 15% tamoxifen
US10/493,166 US20050042279A1 (en) 2001-10-24 2002-10-23 Pharmaceutical formulation comprising more than 15% tamoxifen
JP2003537610A JP2005508971A (ja) 2001-10-24 2002-10-23 製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0125492.9A GB0125492D0 (en) 2001-10-24 2001-10-24 Formulation

Publications (1)

Publication Number Publication Date
GB0125492D0 true GB0125492D0 (en) 2001-12-12

Family

ID=9924411

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0125492.9A Ceased GB0125492D0 (en) 2001-10-24 2001-10-24 Formulation

Country Status (6)

Country Link
US (1) US20050042279A1 (enExample)
EP (1) EP1448171A2 (enExample)
JP (1) JP2005508971A (enExample)
AU (1) AU2002341145A1 (enExample)
GB (1) GB0125492D0 (enExample)
WO (1) WO2003035043A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI547431B (zh) * 2004-06-09 2016-09-01 史密斯克萊美占公司 生產藥物之裝置及方法
CZ297446B6 (cs) * 2004-09-30 2006-12-13 Pliva - Lachema A. S. Zpusob prípravy orální pevné lékové formy a orální pevná léková forma pripravená tímto zpusobem
US10201549B2 (en) * 2013-06-14 2019-02-12 Professional Compounding Centers Of America (Pcca) Testosterone combined with anastrozole injection solutions
CN103393603B (zh) * 2013-07-22 2015-04-01 南通广泰生化制品有限公司 枸橼酸他莫昔芬颗粒
MX390899B (es) 2015-10-30 2025-03-21 Cancer Prevention Pharmaceuticals Inc Formulación de combinación de dosis fija, eflornitina y sulindaco.
CN113133982B (zh) * 2021-03-30 2022-08-02 北京鑫开元医药科技有限公司 一种阿那曲唑片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543370A (en) * 1979-11-29 1985-09-24 Colorcon, Inc. Dry edible film coating composition, method and coating form
US4683256A (en) * 1980-11-06 1987-07-28 Colorcon, Inc. Dry edible film coating composition, method and coating form
GB8501035D0 (en) * 1985-01-16 1985-02-20 Senior J Prostaglandins
US4832956A (en) * 1985-09-25 1989-05-23 Gerhard Gergely Disintegrating tablet and process for its preparation
US5681382A (en) * 1995-08-22 1997-10-28 Shin-Etsu Chemical Co., Ltd. Rapidly soluble coating composition and method for preparing same
US6245352B1 (en) * 1999-04-27 2001-06-12 Eli Lilly And Company Pharmaceutical formulation

Also Published As

Publication number Publication date
WO2003035043A3 (en) 2003-06-05
EP1448171A2 (en) 2004-08-25
AU2002341145A1 (en) 2003-05-06
JP2005508971A (ja) 2005-04-07
WO2003035043A2 (en) 2003-05-01
US20050042279A1 (en) 2005-02-24

Similar Documents

Publication Publication Date Title
GB2359254B (en) Formulation
DE60237965D1 (en) Metalloproteinaseinhibitoren
DE60231477D1 (en) Imidazolderivate
DE60210819D1 (en) Pyrazolopyridazinderivate
DE60141362D1 (en) Ösophagus-stoma-knopf
DE60218514D1 (en) Polyolefin-kunststoffrohre
GB0000891D0 (en) Formulation
EP1353546A4 (en) METHOD AND DEVICE FOR MONITORING PULSATION FOR TREATMENT DEVICE
DE50203686D1 (en) Substituierte c-furan-2-yl-methylamin- und c-thiophen-2-yl-methylamin-derivate
GB0125492D0 (en) Formulation
DE50214962D1 (en) Heterocyclylarylsulfonamide
GB0101992D0 (en) Pesticidal formulation
IL147063A0 (en) Pesticidal formulation
GB2396812B (en) Formulation
GB2375048B (en) Formulation
GB0116619D0 (en) Formulation
GB0106031D0 (en) Use
GB0112497D0 (en) Formulation
GB0115893D0 (en) Formulations
GB0107226D0 (en) Formulations
CA93647S (en) Fauteuil
CA93127S (en) Tilt-latch
CA93075S (en) Travelbag
CA92978S (en) Photo-changer
GB0118830D0 (en) Disinfectant formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)